Last updated on January 2018

A Randomized, Double-blind, Double-dummy, Parallel-group Study Comparing the Efficacy and Safety of Ofatumumab Versus Teriflunomide in Patients With Relapsing Multiple Sclerosis.


Brief description of study

A Randomized, Double-blind, Double-dummy, Parallel-group Study Comparing the Efficacy and Safety of Ofatumumab Versus Teriflunomide in Patients With Relapsing Multiple Sclerosis.

Detailed Study Description

To compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide administered orally once daily in patients with relapsing multiple sclerosis

Clinical Study Identifier: TX147435

Contact Investigators or Research Sites near you

Start Over

Angela Aungst

University of South Florida-Morsani College of Medicine
Tampa, FL USA
  Connect »